President Donald Trump announced last month that the GOP will become “the party of health care,” and news reports suggest he intends to make it a top issue in his reelection campaign. So when Mick Mulvaney, the acting White House chief of staff, touted the administration’s work on prescription drug prices — a hot-button issue […]Continue Reading ...
A casual observer of Wednesday’s House Energy and Commerce subcommittee hearing might think insulin prices just go up by themselves. After all, the key industry executives filed opening statements to the congressional panel outlining patient-assistance programs, coupons and discounts — a range of price reductions that might make one think this life-or-death diabetes medication is […]Continue Reading ...
[khn_slabs slabs=”898461″] Your wonderfully entertaining compiler of “The Friday Breeze,” Brianna Labuskes, is off today, so I’m jumping in to keep you abreast of this week’s vital health care news. Here’s what I found most fascinating, some of it far away from the headlines. Let’s dive into my “Department of Health Studies,” where I found […]Continue Reading ...
When Erin Gilmer filled her insulin prescription at a Denver-area Walgreens in January, she paid $8.50. U.S. taxpayers paid another $280.51. “It eats at me to know that taxpayer money is being wasted,” said Gilmer, who has Medicare and was diagnosed with Type 1 diabetes while a sophomore at the University of Colorado in 2002. […]Continue Reading ...
While the high cost of prescription drug prices seems to be a universally agreed-upon trouble spot in the American health system, a House Ways and Means subcommittee hearing Thursday showed that Democrats and Republicans are still miles apart on what to do about it. The hearing, focused on using Medicare to encourage affordability, competition and […]Continue Reading ...
[khn_slabs slabs=”924915″] Dr. Alan Green’s patients travel from around the country to his tiny practice in Queens, N.Y., lured by the prospect of longer lives. Over the past two years, more than 200 patients have flocked to see Green after learning that two drugs he prescribes could possibly stave off aging. One 95-year-old was so […]Continue Reading ...
Large majorities of Americans from both major parties support steps to control prescription drug costs such as showing prices in ads, removing barriers to generics and letting patients get less expensive drugs from Canada, a new poll shows. By a 9-to-1 ratio, Republicans, Democrats and independents favor making drug companies show list prices in their […]Continue Reading ...
Senators got their first opportunity Tuesday to prod drugmakers about the wallet-emptying prices they charge for prescription drugs. Almost in unison, the executives expressed support for eliminating rebates that flow to industry middlemen instead of patients; for increasing transparency about how they set prices; for shifting to a more value-based pricing system, in which outcomes […]Continue Reading ...
It was back-to-school day at the Senate Finance Committee hearing Tuesday morning. In the third of a series of hearings on rising drug prices, the senators seemed focused on getting an answer to one central question: What the heck is a pharmacy benefit manager? Pharmacy benefit managers, or PBMs, are the go-between companies that negotiate […]Continue Reading ...
Like those of his recent predecessors, President Donald Trump’s proposed budget for the fiscal year that starts in October will not be adopted by Congress. Still, a presidential budget plan is an important indicator of the administration’s priorities. The Trump administration’s priority for health is for the federal government to spend less. In some cases […]Continue Reading ...
[khn_slabs slabs=”828733″ view=”pull-right”] Happy Friday! Headline writers across the world (read: yours truly) breathed a sigh of relief this week when the venture formally known as “the health initiative founded by Amazon, Berkshire Hathaway and JPMorgan Chase” finally picked a name. After more than a year of tight-lipped secrecy, they settled on “Haven.” What do […]Continue Reading ...
Cities and local governments in several states said they will continue to use a Canadian company to offer employees prescription drugs at a highly reduced price, even though federal officials raised safety concerns about the practice last week. The municipalities use CanaRx, which connects their employees with brick-and-mortar pharmacies in Canada, Great Britain and Australia […]Continue Reading ...
[khn_slabs slabs=”828733″] Happy first day of March! Yours truly could barely keep up with all the news coming off Capitol Hill this week (yes, there were other things going on besides a certain high-profile hearing, as hard as that is to believe). So let’s get right to it! Seven Big Pharma executives were hauled in […]Continue Reading ...
House Democrats, led by Rep. Pramila Jayapal (D-Wash.), have formally introduced their “Medicare-for-all” legislation. The bill, which would ensure coverage for almost every medical service most people need, did not come with any suggestions for financing. But it will likely reflect the far-left end of the Democratic debate in progress. Meanwhile, the CEOs of seven […]Continue Reading ...
Florida Gov. Ron DeSantis said Wednesday he intends to bring down skyrocketing drug prices by leaning on an existing federal law that could enable the state to import prescription meds wholesale from Canada, where they’re much cheaper. He’s citing direct support from President Donald Trump, whose administration would have to approve the endeavor. “He not […]Continue Reading ...
- Vanderbilt investigators discover link between vascular biology and eye disease
- Feces transplantation is effective and provides economic benefits
- Eisenhower Health first in Southern California to offer new lung valve treatment for COPD/emphysema
- Johns Hopkins researchers uncover role of neurotransmitter in the spread of aggressive cancers
- Porvair Sciences offers highly effective P3 microplate for biological sample clean-up
- Air pollution increases risk for respiratory hospitalization among childhood cancer survivors
- We are sitting more! How bad is that?
- ADHD Screening: MedlinePlus Lab Test Information
- Cellular alterations increase vulnerability of obese and diabetic individuals to infection
- Association Insurance Pushes On Despite Court Ruling
- Traditional and e-cigarette users may be more receptive to smoking cessation interventions
- Delving into tumor’s cellular lineage may offer clues for customized therapies
- Two studies uncover brain mechanisms underlying decision making process
- Cardiometabolic Risk Better ID’d in Children Reclassified to Higher BP
- How the obesity epidemic is taking a toll on our bones and joints
- E-cigarettes contaminated with dangerous microbial toxins
- Researchers document specific characteristics of storefront tobacco advertisements
- Oncotype DX-guided treatment could reduce cost for breast cancer care, study suggests
- New review highlights how lifestyle affects our genes
- Study provides evidence that blood tests can detect Alzheimer’s risk